PUBLIC PORTAL

MEDICALLY REVIEWED

HSA approves Belimumab (Benlysta) for Lupus Nephritis

Share on email
Share on print
Share on whatsapp

Belimumab is a fully human IgG1λ recombinant monoclonal antibody directed against B lymphocyte stimulator. Know more about its drug profile . . .

Sign Up or Log In as a healthcare professional to read the full article

Share via

Share on email
Share on facebook
Share on whatsapp
Share on telegram
Share on twitter
Share on linkedin

Also worth reading